Essex Woodlands Healthcare Partners β Full Portfolio
30 tracked investments Β· listed companies and verified rows first
Co-investorsNippon Venture Capital
BiotechMarietta, US
William C. Taylor(Executive Officer, Director)Parker H. Petit(Executive Officer, Director)Alexandra O. Haden(Executive Officer)Michael J. Senken(Executive Officer)
BoardLarry W. Papasan(Director)Neil S. Yeston(Director)
HealthtechLaguna Hills, US
Bjarne Bergheim(Executive Officer, Director)John McGaugh(Executive Officer)John Bostjancic(Executive Officer)Hugh Neuharth(Executive Officer)
BoardOlav Bergheim(Director)Olav B. Bergheim(Director)
PartnerBrooks AndrewsΒ· led
Co-investorsFjord VenturesGeneral AtlanticMeritech Capital PartnersOrbiMedWelsh, Carson, Anderson & Stowe
BiotechMalvern, US
Antony Koblish(Executive Officer, Director)Francis Conway(Executive Officer)Maarten Persenaire(Executive Officer)Christine Arasin(Executive Officer)Vince Burgess(Director)
BoardKevin Rakin(Director)
Co-investorsCheckmate Capital Group LLCOrbiMedSignet Healthcare Partners1315 Capital
HealthtechIrvine, US
John McDermott(Executive Officer, Director)Robert D. Mitchell(Executive Officer)Vaseem Mahboob(Executive Officer)
BoardGuido J. Neels(Director)Daniel Lemaitre(Director)Gregory D. Waller(Director)
Board seatGuido NeelsΒ· per SEC Form D Β· $210.5M raise Β· filed Aug 2018
Impulse Dynamics develops implantable medical device technology for cardiac care, with a background in biomedical research and implantable cardiac electronics.
BiotechHardwareHealthtechMedical DevicesDublin 2, US
Shlomo Ben-Haim(Director)Jason Spees(Chief Executive Officer)Paul Bae(Chief Administrative Officer and General Counsel)David Prutchi(Executive Vice President, Chief Technology Officer)Richard J. Buchholz(Chief Financial Officer)Anthony Hong(Chief Science and Strategy Officer)
Board seatGuido NeelsΒ· per SEC Form D Β· $140M raise Β· filed Mar 2025
Co-investorsAmzak HealthSignet Healthcare Partners
BiotechPalatine, US
Albert W. Brzeczko(Executive Officer)George K. Ross(Director)James F. Emigh(Executive Officer)Peter A. Clemens(Executive Officer)Robert B. Jones(Executive Officer, Director)Robert Seiser(Executive Officer)
Co-investorsGalen Partners
Bioventus develops orthobiologics and pain treatment products for orthopedic care, offering therapies such as the StimRouter neurostimulation device for chronic peripheral nerve pain.
BiotechHealthtechMedical Devices
Co-investorsAlta PartnersAmpersand
French natural medicine company offering a portfolio of natural, science-based innovative and personalized pharmaceutical products
Cardiva Medical, part of Haemonetics, develops the VASCADE family of vascular closure systems, including venous and arterial closure devices used in cardiovascular procedures.
HardwareHealthtechMedical DevicesSanta Clara, US
George Lee(Director)Lisa Garrett(Executive Officer)Michael Bornitz(Director)Rick Anderson(Director)John Russell(Executive Officer, Director)Augustine Lien(Director)
Co-investorsEvidity Health CapitalLuther King Capital ManagementPTV Healthcare Capital
PartnerEvis HurseverΒ· led
HealthtechNew York, US
Stuart Goldberg(Executive Officer)Andrew Pecora(Director)Eric Schultz(Executive Officer, Director)Elizabeth Rushforth(Executive Officer)Thomas Gallucci(Executive Officer)Andrew Norden(Executive Officer)
Co-investorsBoston Millennia Partners
HealthtechMalvern, US
Robert Moccia(Executive Officer, Director)
Co-investors1315 Capital
Electronics product development and contract manufacturing partner specializing in medical devices
PartnerBrooks AndrewsΒ· led
Co-investorsAdvent Life SciencesSV Health Investors
Germfree designs, engineers, and manufactures controlled environments including mobile cleanrooms, modular facilities, and cleanroom equipment such as biosafety cabinets, aseptic isolators, and decontamination systems.
BiotechHardwareHealthtech
Carol Houts(Chief Executive Officer)
Majorelle is a French pharmaceutical laboratory that develops treatments, medical devices, and health products across three therapeutic areas: women's health, urology, and family health.
BiotechFemTechHealthtech
PartnerEvis HurseverΒ· led
Metabolon provides metabolomics services and bioinformatics tools that measure small molecules to give biological context to research data.
AI & Machine LearningBiotechHealthtechDurham, US
John A. Ryals(Executive Officer, Director)Gerald M. Haines II(Executive Officer)Rohan F. Hastie(Executive Officer, Director)
BoardJohn Oxaal(Director)R. Scott Barry(Director)R. John Fletcher(Director)
Co-investorsCamden PartnersHavencrest Capital ManagementRevelation PartnersSyngenta Group Ventures
Prolacta Bioscience manufactures 100% human milk-based nutritional products and fortifiers for premature and critically ill infants in hospital neonatal intensive care units.
BiotechHealthtechMedical DevicesCity Of Industry, US
Scott Elster(Executive Officer, Director)John M. Shields(Executive Officer)
BoardFrank Foster(Director)Martin Sutter(Director)David Brailer(Director)Dan Janney(Director)
Co-investorsAisling CapitalFrontier Venture CapitalPROOFAlta Partners
HealthtechSan Diego, US
Nicholas L. Teti, Jr.(Executive Officer, Director)Joseph A. Newcomb(Executive Officer)Stewart M. Brown(Executive Officer)
BoardClarke B. Futch(Director)Paul J. Hadden(Director)Todd C. Davis(Director)
Co-investorsBioBrit
Venus develops non-invasive, energy-based medical aesthetic devices for body, face, skin, and hair treatments, integrating robotics, AI, and IoT technologies.
BiotechHardwareHealthtechMedical DevicesToronto, US
Domenic Serafino(Executive Officer, Director)Kirk Gunhus(Executive Officer)Ross Portaro(Executive Officer)Anna Georgiadis(Executive Officer)Melissa Kang(Executive Officer)Michael Mandarello(Executive Officer)
Co-investorsAPERTURE Venture PartnersLongitude CapitalClarusHealthQuest Capital
HealthtechCampbell, US
Nersi Nazari(Executive Officer, Director)Steve Zadig(Executive Officer, Director)
BoardRichard Feachem(Director)Tom Saunders(Director)
Co-investorsAsahi Kasei Corporate Venture CapitalRevelation PartnersMVM Life Science Partners
HealthtechSan Antonio, US
Mark Stibich(Chief Scientific Officer)Julie Stachowiak(Chief Epidemiologist)John Wisniewski(VP of Strategic Accounts)Paul Froutan(Chief Operating Officer)Mike DelVacchio(VP of Sales and Marketing)Morris Miller(Chief Executive Officer)
Co-investorsBattery Ventures
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.


